Walder Wyss with Microcaps on equity investment by Givaudan

Walder Wyss advised Microcaps as Givaudan made an equity investment and entered a strategic collaboration with the company to bolster its encapsulation capabilities.

Givaudan is a globally active specialist in fragrance and beauty segment. Microcaps emerged from ETH Zurich’s Complex Materials Group. It is built on a microfluidic technology that provides encapsulation solutions for the cosmetic, nutraceutical, and health and life science sectors.

The Walder Wyss team

The Walder Wyss team was led by partner Urs P. Gnos (corporate/M&A) and counsel Samuel Lieberherr (corporate/M&A) and included counsel Stefan Walder (corporate/M&A), managing associate Alice Vorburger (corporate/M&A), partner Monique Sturny (antitrust/competition) and partner Mark A. Reutter (IP/IT).